Adverse Effects of Tocilizumab Versus Baricitinib in Severe COVID-19
Description
No abstract
PubMed COVID-19 Clinical Care
3671 - 3680 of 6921 results found
A typology of healthcare pathways after hospital discharge for adults with COVID-19: the evolution of UK services during pandemic conditions
Description
INTRODUCTION: Over half of post-COVID-hospitalisation adults have persistent symptoms 2 years after discharge, providing a challenge for individuals and healthcare systems. We therefore aimed to describe a typology of UK healthcare pathways post
Association among COVID-19, multisystem inflammatory syndrome in children, and oral health status. Braz Oral Res. 2023;37:e072
Description
[This corrects the article doi: 10.1590/1807-3107bor-2023.vol37.0072].
Achyrocline satureioides as an adjuvant therapy for the management of mild viral respiratory infections in the context of COVID-19: Preliminary results of a randomized, placebo-controlled, and open-label clinical trial
Description
We evaluated the impact of an Achyrocline satureioides inflorescence infusion on the clinical outcomes of viral respiratory infections, including those caused by SARS-CoV-2, in a monocentric, randomized, open-label, placebo-controlled clinical trial
A comparison of the infant gut microbiome before versus after the start of the covid-19 pandemic
Description
The COVID-19 pandemic and resulting public health directives led to many changes in families' social and material environments. Prior research suggests that these changes are likely to impact composition of the gut microbiome, particularly during
Amantadine in unvaccinated patients with early, mild to moderate COVID-19: a randomized, placebo-controlled, double-blind trial
Description
CONCLUSIONS: The central effects on the nervous system with reduction of sleepiness and depression might have had a supportive effect on faster recovery in early COVID-19 patients.
Advancement of Computational Design Drug Delivery System in COVID-19: Current Updates and Future Crosstalk- A Critical update
Description
Positive strides have been achieved in developing vaccines to combat the coronavirus-2019 infection (COVID-19) pandemic. Still, the outline of variations, particularly the most current delta divergent, has posed significant health encounters for
A Quick Test to Objectify Smell and Taste Dysfunction at Home: a Proof-of-Concept for the Validation of the Chemosensory Perception Test
Description
Recent studies have shown the efficacy of a home test for the self-evaluation of olfactory and gustatory functions in quarantined COVID-19 patients. However, testing was often limited to COVID-19 participants, and the accuracy of home test kits was
Antibody responses to an inactivated SARS-CoV-2 vaccine in individuals aged from 50 to 102 years
Description
CONCLUSION: The inactivated SARS-CoV-2 vaccine is effective in individuals aged 50 and older. This is the first study that has found an inverse dose-response relationship between ages and the low-level TAs. Older people, especially those with chronic